172 AJTCCM VOL. 29 NO. 4 2023
ORIGINAL RESEARCH: BRIEF REPORTS
D). Of the 18 cases, 17 yielded conrmatory pleural biopsy samples
(Supplementary Table 1, available online at https://www.samedical.org/
le/2143). ere was positive correlation in 4 out of 7 MPEs (57.1%).
Six patients were diagnosed with adenocarcinoma, of whom 4 (66.7%)
had PFR consistent with malignancy; one did not have IHC staining.
One patient had squamous cell carcinoma on biopsy, but PFR only
demonstrated inammatory cells. Histological examination of PFR
revealed malignant columnar cells trapped within brin or blood clot,
either arranged in a glandular pattern or singly distributed (Fig.1D). e
cytomorphology of PFR and its feasibility for IHC staining are similar
to those of pleural biopsy samples, although PFR has less cellularity
and poorer architectural visualisation (Fig.1A andC). We did not do
mutational analysis.
Four patients had TPE on pleural biopsy, but their PFR demonstrated
only inammatory cells. Diagnoses of uraemic pleuritis (n=1) and
parapneumonic eusion (n=5) were made based on clinical history
and examination, combined with absence of features of tuberculosis on
pleural biopsy. e overall negative correlation was 6 out of6 PE/TPE
cases. Both PFR and thoracoscopic pleural biopsy were concordant in
terms of the presence of inammatory cells, but PFR added no further
information.
In this proof-of-concept study, we demonstrated that PFR
contributes valuable histopathological information in the diagnosis
of cytology-negative malignant pleural effusion. Its fibrin-based
morphology is comparable to that of chest drain clumps previously
described.[4] PFR is morphologically comparable to pleural biopsy,
and immunohistochemical staining is feasible. Despite having less
cellularity, it is still theoretically sucient for mutational analysis.
In contrast to pleural fluid cytology, in which pleural fluid is
centrifuged to exclude any debris or sediments and subsequently
smeared for analysis, diagnostic information from PFR is obtained from
the debris found in pleural uid. PFR also diers from a cytology cell
block in that it does not require additives such as plasmaandthrombin
to enmesh the cellular material. Furthermore,PFR can be processed at
the patient’s bedside and immediately xed in formalin. is technique
could potentially negate the need for pleural biopsy in suspected
malignant pleural eusion, which would be particularly helpful in
patients who are not suciently stable formedical thoracoscopy, or
those who are far from a tertiary centre with the necessary equipment
to perform medical thoracoscopy.
It is likely that granulomas do not exist in TPE, as they are formed by
a lymphocyte-driven, macrophage-initiated immune reactionwhich
requires blood supply that is only present within the pleura.[6]
One would not expect to see acid-fast bacilli on histopathological
examination, given that tuberculous fluid is paucibacillary as a
resultof T-helper cell compartmentalisation and eective containment
of tuberculous bacilli.[2]
The present study is not without limitations. First, inconsistent
presence of PFR on ltration raises questions as to whether the ltration
method could be improved, or whether brin-containing residue is
uniformly formed in all kinds of malignant eusion; and if so, how
soon it forms. It is conceivable that a smaller mesh size could improve
PFR yield by capturing smaller residue, but this needs to be studied
further. Second, mutational analysis was not carried out. ird, the
potential role of PFR being ltered from newly inserted chest drains
was not explored in our study. Fourth, a small sample size and single-
centre setting reduces the generalisability of the ndings. Fih, the
usefulness of PFR for other types of malignancy is unproven, as only
adenocarcinoma was diagnosed in this study. ese limitations will be
addressed in a future pilot study.
PFR provides valuable diagnostic information to assist in the diagnosis
of malignant pleural eusion, but does not carry the histopathological
information necessary to diagnose pleural tuberculosis. Head-to-head
studies on the usefulness of PFR and cytology cell block may elucidate
PFR’s diagnostic potential. Future studies are needed to explore its role
in patients with newly inserted chest drains or non-adenocarcinoma
malignancy, and its suitability for mutational analysis.
Declarations. Written informed consent was obtained from the patients
for publication of this article and the accompanying images. A copy of
the written consent is available upon request from the Editor-in-Chief of
this journal. is study was approved by the Medical Research & Ethics
Committee of Malaysia (NMRR ID-22-02491-IED).
Acknowledgements. None.
Author contributions. Conceptualization: LEN, HYR, NCH.
Methodology: LEN, HYR, NCH. Formal analysis: TR, MABAA.
Investigation: LEN, NCH, HYR, JLL, KTR, SL, MGL. Data curation:
JLL, LEN, MGL, KTR, NCH, HYR. Writing – Original dra: LEN, NCH,
HYR. Writing-Review and Editing: HYR, NCH, KKSK, TR, MABAA, SL.
Supervision: KKSK, HYR, NCH
Funding. None.
Conict of interest. None.
1. Kannan SK, Lin WJ, Teck TS, Azizi ARJ. Pleuroscopy: Early experience in an East
Malaysian state with high tuberculosis prevalence. J Bronchology Interv Pulmonol
2009;16(4):250-253. https://doi.org/10.1097/LBR.0b013e3181ba730a
2. Shaw JA, Diacon AH, Koegelenberg CFN. Tuberculous pleural eusion. Respirology
2019;24(10):962-971. https://doi.org/10.1111/resp.13673.
Fig.1. Histopathological comparison between pleural tissue obtained
through pleural biopsy (A and B) and from PFR (C and D). Both samples
displayed strong and diuse immunoreactivity for TTF-1 (Aand C, 20×).
Under H&E staining, PFR demonstrated satisfactory cellularity, albeit
admixed with brin (D). Cytomorphological features were comparable and
characterised by malignant cells arranged in cords, nests and glandular
structures, with round to oval nuclei showing vesicular chromatin texture,
conspicuous nucleoli and a modest amount of eosinophilic cytoplasm
(B and D, H&E, 40×). (PFR = pleural uid residue; TTF-1 = thyroid
transcription factor-1; H&E = haematoxylin and eosin.)